In a large mixed heart failure (HF) community cohort (n=250), individualized management guided by BVA significanlty improved key outcomes vs Medicare benchmarks1
Retrospective analysis of n=250 patients treated in an East Coast community hospital HF practice, 2008-2012, who underwent BVA at least once and for whom at least 1 year of follow-up data were available or death was recorded within 1 year. Cohort outcomes, which were not risk-adjusted, were analyzed vs institutional (30-day) or national (365-day) Medicare benchmarks.2 Decongestion and anemia management strategies were per best clinical judgment integrating BVA results alongside other data. Patients were 41% female and 59% male; age range was 42 to 95 years; 46% had reduced and 54% preserved ejection fraction, with an ejection fraction range of 10%-80%; 30% had Stage 4 and 58% Stage 2 or 3 chronic kidney disease.
Volume and red blood cell status heterogeneity was high, suggesting a medical need for the direct, accurate evaluation only possible with BVA.
Points of contact in HF care at which to consider direct BVA
The extent, composition and distribution of volume overload in decompensated heart failure are highly variable, and this variability needs to be taken into account in the approach to individualized therapy.“3
- Wayne L.Miller, M.D.